Today, I’d like to invite you to take a look at the 5 posts describing a pathway that saw the most visits on our blog in 2014. 

Just follow the links if you haven’t read them yet (or if you want to browse them again, feel free!).

Winter is coming. It’s getting colder, days are getting shorter… and Christmas might still seem a long way off (or maybe not long enough if there’s still all the shopping to be done!).

Bring some light and festive happiness to your day and get into the seasonal spirit!  Scratch a window every day in December on tebu-bio’s virtual Advent Calendar and you might win some chocolates (the real thing, not virtual ones though!).

And… in good tradition, on Christmas Eve there will be a big box for the final happy winner…

October is Breast Cancer Awareness Month, an annual campaign to increase awareness of the disease. Like a lot of our American partners (Rockland, Cedarlane), tebu-bio has decided to participate in this action.  So… October will be pink at tebu-bio!

Breast Cancer is a major public health concern. It’s considered that one woman in nine will develop breast cancer during her life. The earlier breast cancer is detected, the higher the chances are of being cured.

With more than 100 types of cancers affecting any part of the body, cancer is one of the leading causes of death in the world. It has an enormous impact on well-being, both for those with the diagnosis and for those who surround them. Understanding and eventually treating or preventing this diverse group of cell growth diseases has been, and will continue to be a major focus of the medical and research communities.

A variety of popular cancer research tools exists and can be divised into categories. We’ll try to summarize them into few posts. Today, I’d like to focus on inhibitors known to be active on the Ubiquitin/Proteasome Pathway.